Page Title
Drug Development Pipeline
TB Alliance
Status
DiscontinuedTherapeutic Approach
Anti-Infective
This program worked to identify and test potential treatments for infections caused by Mycobacterium abscessus (M. abscessus) and Mycobacterium avium complex (MAC), two types of nontuberculous mycobacteria (NTM).
Status
No further development in CF is planned at this time.
Sponsor
This program was sponsored by TB Alliance, in partnership with Johns Hopkins University, and was partially funded by the Cystic Fibrosis Foundation.
CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.
Learn More